0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus

Journal of Dermatological Treatment

Volumn 15, Issue 1, 2004, Pages 63-64

  Drüke, Anja ^a   Gambichler, T ^a   Altmeyer, P ^a   Freitag, M ^a   Kreuter, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CYCLOSPORIN; CYTOKINE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS;

ADULT; CASE REPORT; CUSHING SYNDROME; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKOPENIA; LIVER TOXICITY; LUPUS ERYTHEMATOSUS; NEPHROTOXICITY; OINTMENT; PAIN; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; TREATMENT OUTCOME;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; OINTMENTS; TACROLIMUS;

EID: 10744223677     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630310017852     Document Type: Letter

References (9)

1. Yoshimasu T, Ohtani T, Sakamoto T et al. Topical FK506 (tacrolimus) therapy for skin lesions of cutaneous lupus erythematodes and dermatomyositis. Eur J Dermatol (2002) 12: 50-52.
2. Furukawa F, Yoshimasu T, Ohtani T et al. Topical tacrolimus therapy for lesions of cutaneous lupus erythematosus: reply to the comments of Drs. Walker. Kirby and Chalmers. Eur J Dermatol (2002) 12: 389 (letter).
3. Walker SL, Kirby B, Chalmers RJG. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Eur J Dermatol (2002) 12: 387-8 (letter).
4. Kanekura T, Yoshii N, Terasaki K et al. Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol (2003) 148: 353-6.
5. Peters DH, Fitton A, Plosker GL, Faulds D. Tacrolimus: a review of its pharmacology and therapeutic potential in hepatic and renal transplantation. Drugs (1993) 46: 746-94.
6. Heilig B, Fiehn C, Brockhaus M et al. Evaluation of soluble tumour necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol (1993) 13: 321-8.
7. Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol (1997) 36: 191-6.
8. Griffiths B, Emery P. The treatment of lupus with cyclosporin A. Lupus (2001) 10: 165-70.
9. Duddridge M, Powell RJ. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus: a report of three cases. Ann Rheum Dis (1997) 56: 690-93.